Work

Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression

Year: 2008

Type: article

Source: Cancer Immunology Immunotherapy

DOI: 10.1007/s00262-008-0562-x

Authors: Jennifer A. Wargo, Paul F. Robbins, Yong Li, Yangbing Zhao, Mona El-Gamil, Diana Caragacianu, Zhili Zheng, Julie A. Hong, Stephanie Downey, David S. Schrump, Steven A. Rosenberg, Richard A. Morgan

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Institutes of Health

Award: G9000030644

OpenAlex ID: W2072709919

FWCI: 3.241

Cites: 38

Cited by: 87

Related to: 10